Eriko Kinugasa
- Nephrology top 0.5%
- Surgery
- Pathology and Forensic Medicine top 10%
- Nutrition and Dietetics top 5%
- Hematology top 5%
- Co-authors
- Tadao AkizawaEtsuro OgataFumihiko KoiwaMasahide MizobuchiShozo KoshikawaAlejandro GugliucciSatoshi KimuraIkuji Hatamura
- Topics
- Parathyroid Disorders and Treatments (30 papers)Dialysis and Renal Disease Management (12 papers)Vitamin D Research Studies (11 papers)
- Partner nations
- JapanUnited States
In The Last Decade
Eriko Kinugasa
77 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 82
- Nephrology 697
- Surgery 220
- Pathology and Forensic Medicine 220
- Nutrition and Dietetics 191
- Hematology 182
Countries citing papers authored by Eriko Kinugasa
This map shows the geographic impact of Eriko Kinugasa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eriko Kinugasa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eriko Kinugasa more than expected).
Fields of papers citing papers by Eriko Kinugasa
This network shows the impact of papers produced by Eriko Kinugasa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eriko Kinugasa. The network helps show where Eriko Kinugasa may publish in the future.
Co-authorship network of co-authors of Eriko Kinugasa
This figure shows the co-authorship network connecting the top 25 collaborators of Eriko Kinugasa. A scholar is included among the top collaborators of Eriko Kinugasa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eriko Kinugasa. Eriko Kinugasa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 14 | |
| 2 | 14 | |
| 3 | 7 | |
| 4 | 30 | |
| 5 | 34 | |
| 6 | 4 | |
| 7 | 4 | |
| 8 | 48 | |
| 9 | 13 | |
| 10 | 5 | |
| 11 | 2 | |
| 12 | 87 | |
| 13 | 10 | |
| 14 | 15 | |
| 15 | 11 | |
| 16 | 7 | |
| 17 | Very high incidence and relatively mild clinical symptoms of dialysis population with hypoparathyroidism | 1 |
| 18 | 1 | |
| 19 | 18 | |
| 20 | The benefit of hydroxyapatite(HA) for the biocompatibility and adhesion to the soft tissues. | 1 |
About Eriko Kinugasa
Eriko Kinugasa is a scholar working on Nephrology, Hematology and Clinical Biochemistry, having authored 77 papers that have together received 1.1k indexed citations. Recurring topics across this work include Parathyroid Disorders and Treatments (30 papers), Dialysis and Renal Disease Management (12 papers) and Vitamin D Research Studies (11 papers). The work is most often cited by research in Nephrology (697 citations), Clinical Biochemistry (112 citations) and Hematology (182 citations). Eriko Kinugasa has collaborated with scholars based in Japan and United States. Frequent co-authors include Tadao Akizawa, Etsuro Ogata, Fumihiko Koiwa, Masahide Mizobuchi, Shozo Koshikawa, Alejandro Gugliucci, Satoshi Kimura, Ikuji Hatamura, Fumie Saji and Shigeo Negi. Their work appears in journals such as Journal of Clinical Oncology, PLoS ONE and Biochemical and Biophysical Research Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.